What is the current Viral Testing market size?

The Viral Testing market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Viral Testing market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Viral Testing market?

Key drivers include rising viral infections, advancements in technology, and growing awareness of viral diseases.

What are the major challenges facing the Viral Testing market?

Challenges include high costs, limited accessibility, and stringent regulatory requirements.

Which regions are leading the Viral Testing market?

North America and Europe are currently leading, due to well-established healthcare infrastructure.

Who are the top companies in the Viral Testing market?

Top companies include Roche, Abbott, and bioMerieux, offering a range of viral testing solutions.

What future opportunities exist in the Viral Testing market?

Future opportunities include emerging markets, point-of-care testing, and molecular diagnostics.

How is technology impacting the Viral Testing market?

Technology is driving growth through advancements in nucleic acid testing, next-generation sequencing, and digital platforms.

What is the current regulatory landscape for the Viral Testing market?

The regulatory landscape is evolving, with increasing focus on safety, efficacy, and harmonization of standards.

What is the future outlook for the Viral Testing market?

The future outlook is positive, with growing demand, increasing innovation, and expanding applications.

How Big Is the Viral Testing Market? Size, Share & Forecast 2033

Viral Testing by Application (Laboratory, Hospital, Home Care, Academic Institute), by Types (Direct Fluorescent Antibody (DFA) Test, Immunochromatographic Assay, RT-PCR-Based Test, Agglutination Assay, Flow-Through Assay, Solid-Phase Assay), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Viral Testing Market Overview

The Viral Testing market refers to the industry involved in the development and distribution of testing solutions for viral diseases. As the global healthcare landscape continues to evolve, the Viral Testing market size is expected to experience significant growth, driven by advancements in technology, increasing demand for accurate diagnostic solutions, and the need for effective disease surveillance. The growth outlook for the Viral Testing market is promising, with a projected market size of approximately $4.5 billion by 2026. The market forecast suggests a compound annual growth rate (CAGR) of around 6-8% during the forecast period, driven by the expanding industry expansion of point-of-care testing and molecular diagnostics. The scope of the Viral Testing market encompasses various segments, including PCR, immunodiagnostics, and next-generation sequencing.

Loading chart…

The key forces shaping the Viral Testing market include technological advancements, such as the development of rapid diagnostic tests and portable diagnostic devices, as well as changing regulatory landscapes and shifting consumer behaviors. The largest region in the Viral Testing market is currently North America, while the fastest-growing region is Asia-Pacific, driven by increasing healthcare expenditure and government initiatives to improve disease surveillance. As the global healthcare landscape continues to evolve, the Viral Testing market is expected to experience significant growth, driven by the need for accurate and reliable diagnostic solutions.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.72 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche; Agilent Technologies; Thermo Fisher Scientific; QIAGEN International; Lonza; Wuxi Pharmatech (Cayman); Merck; Eurofins Scientific; General Electric; Danaher; Bio-Rad Laboratories; BD; Biospherix; Novogene Corporation; Sartorius
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Viral Testing market is poised for significant growth, driven by various factors. The market dynamics are shaped by several key elements, including growth drivers, restraints, opportunities, and challenges.

Growth Drivers2 items

Advancements in molecular diagnostics and genomic sequencing technologies are fueling the growth of the Viral Testing market size, enabling faster and more accurate detection of viral infections.

Increasing government initiatives and public-private partnerships are driving the adoption of viral testing solutions, particularly in emerging economies, thereby contributing to the growth forecast of the market.

Restraints2 items

High development costs and regulatory hurdles are restraining the growth of the Viral Testing market, making it challenging for new players to enter the market and for existing players to launch new products.

The global shortage of reagents and other essential supplies is affecting the production and distribution of viral testing kits, thereby limiting the Viral Testing market size.

Opportunities2 items

The increasing demand for point-of-care testing and home-based testing solutions presents opportunities for players in the Viral Testing market to develop innovative, user-friendly, and affordable products.

The growing focus on personalized medicine and precision diagnostics is creating opportunities for the development of targeted and tailored viral testing solutions, driving the growth forecast of the market.

Challenges2 items

The complexity of viral mutations and emerging strains poses significant challenges for the development of effective viral testing solutions, requiring continuous research and development efforts.

The need for standardized protocols and harmonized regulations across different regions and countries is a major challenge for the Viral Testing market, affecting the comparability and reliability of test results.

Market Segmentation

Loading chart…

The Viral Testing segmentation is a critical aspect of understanding the market dynamics. In terms of Application, the viral testing market can be broadly categorized into diagnostic and research applications. Diagnostic applications account for a significant share of the market, driven by the increasing prevalence of viral diseases and the need for accurate diagnosis. Research applications, on the other hand, are driven by the growing demand for viral testing in clinical trials and basic research.

The Types of viral testing can be further segmented into molecular diagnostics, immunodiagnostics, and other types. Molecular diagnostics is the largest segment, driven by the increasing adoption of PCR and NAT technologies. Immunodiagnostics is also a significant segment, driven by the growing demand for ELISA and rapid tests. Other types of viral testing, such as cell culture and serology, are also used in various applications.

Viral Testing Segmentation Breakdown12 items

Application

Laboratory

Hospital

Home Care

Academic Institute

Types

Direct Fluorescent Antibody (DFA) Test

Immunochromatographic Assay

RT-PCR-Based Test

Agglutination Assay

Flow-Through Assay

Solid-Phase Assay

Regional Insights

Loading chart…

The Viral Testing market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 35% of the global market, and also the fastest-growing region, driven by increasing adoption of advanced diagnostic technologies, government policies supporting healthcare infrastructure development, and significant investments in research and development. In North America, key drivers include a mature ecosystem, high infrastructure development, and a large patient population, contributing to a 25% share of the global market.

In Europe, the demographics of an aging population and the need for efficient diagnostic solutions are driving the market, contributing to a 20% share. Latin America and Middle East & Africa are expected to contribute 10% and 10% respectively, driven by increasing awareness of viral diseases, improving healthcare infrastructure, and growing demand for diagnostic services. The regional forecast indicates a positive trend for the Viral Testing market, with the Asia Pacific region expected to dominate the market in the coming years.

Competitive Landscape

The Viral Testing market is moderately consolidated, driven by a mix of global players and local companies. The Viral Testing competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships to maintain their market position, while local companies leverage their regional presence and cost advantages to compete.

Companies in the Viral Testing market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies focus on technology, service model, channel strength, customization, and cost advantages. The following companies have notable strategic focuses:

Roche: regional expansion

Agilent Technologies: innovation pipeline

Thermo Fisher Scientific: vertical integration

QIAGEN International: premium pricing

Lonza: local manufacturing

Wuxi Pharmatech: OEM tie-ups

Key Viral Testing Companies15 items

Roche

Agilent Technologies

Thermo Fisher Scientific

QIAGEN International

Lonza

Wuxi Pharmatech (Cayman)

Merck

Eurofins Scientific

General Electric

Danaher

Bio-Rad Laboratories

Biospherix

Novogene Corporation

Sartorius

Market Ecosystem

The Viral Testing ecosystem encompasses a complex network of stakeholders, spanning upstream technology providers and suppliers to downstream end users. Value is created and captured as raw materials and components are transformed into testing solutions, which are then integrated and distributed to various customer segments. This ecosystem can be broadly segmented into three main stages: upstream, midstream, and downstream, with each stage comprising distinct participants and interactions that influence the overall flow of value.

Raw material suppliers — providing reagents and consumables

Technology providers — developing diagnostic platforms

OEMs / manufacturers — producing testing equipment

System integrators / EPCs — configuring testing systems

Distributors / channel partners — supplying testing solutions

Service providers / after-sales — offering maintenance and support

Regulators/standards bodies — establishing testing protocols

In the Viral Testing ecosystem, control points are primarily held by regulators and standards bodies, as they influence adoption by setting testing protocols and approving diagnostic solutions. Dependency risks arise from input constraints, such as the availability of raw materials, and standards, which can impact the development and distribution of testing solutions. Switching costs and partnerships also play a crucial role, as they can affect the interoperability of testing systems and the ability of end users to adopt new solutions. Furthermore, the ecosystem differs by region, with varying regulatory requirements and testing protocols influencing the deployment of viral testing solutions, highlighting the need for a comprehensive value chain analysis to navigate the Viral Testing ecosystem effectively.

Recent Industry Insights

The Viral Testing industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships have been formed to enhance testing capabilities, such as collaborations between diagnostic companies and research institutions. There have also been strategic mergers and acquisitions, aiming to expand product portfolios and strengthen market positions. Additionally, several product and technology launches have taken place, focusing on improving testing accuracy and speed.

Regulatory changes have played a crucial role in shaping the industry, with updated guidelines on testing protocols and in-vitro diagnostic device approvals. A shift in consumer trends towards at-home testing kits has been observed, driven by increased demand for convenience and accessibility. Furthermore, funding rounds and expansions have been secured by key players to support research and development, driving innovation in the Viral Testing industry.

Analyst Overview

As the Lead Analyst, my expert view on the Viral Testing market is that it presents a highly attractive opportunity for growth, driven by increasing demand for rapid and accurate testing solutions. The competitive intensity is moderate, with key players investing heavily in research and development to improve test sensitivity and specificity. Looking ahead, the long-term Viral Testing market outlook is positive, with innovations in technologies such as PCR and serology expected to drive growth. However, the demand-supply balance may be affected by key risk factors such as supply chain disruptions and regulatory changes.

11 items

1. Executive Summary

2. Viral Testing Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Viral Testing Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Viral Testing Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Laboratory

6.1.2. Hospital

6.1.3. Home Care

6.1.4. Academic Institute

6.2. Global Viral Testing Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Direct Fluorescent Antibody (DFA) Test

6.2.2. Immunochromatographic Assay

6.2.3. RT-PCR-Based Test

6.2.4. Agglutination Assay

6.2.5. Flow-Through Assay

6.2.6. Solid-Phase Assay

6.3. Global Viral Testing Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Viral Testing Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Viral Testing Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Viral Testing Market Competition by Key Manufacturers

8.1. Global Viral Testing Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Viral Testing: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Roche

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Agilent Technologies

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Thermo Fisher Scientific

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. QIAGEN International

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Lonza

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Wuxi Pharmatech (Cayman)

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Merck

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Eurofins Scientific

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. General Electric

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Danaher

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Bio-Rad Laboratories

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. BD

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Biospherix

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Novogene Corporation

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Sartorius

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Viral Testing Market

Figure 4: Global Viral Testing Market: Drivers

Figure 5: Global Viral Testing Market: Challenges

Figure 6: Global Viral Testing Market: Trends

Figure 7: Global Viral Testing Market: Opportunity

Figure 8: Global Viral Testing Market: Restraint

Figure 9: Global Viral Testing Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Viral Testing Market Value (USD Million) By Region

Figure 15: Global Viral Testing Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Viral Testing Market Value (USD Million) By Region

Figure 23: Global Viral Testing Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global Viral Testing Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Viral Testing Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Viral Testing Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Viral Testing Market Value (USD Million) By Region

Table 10: Global Viral Testing Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Viral Testing Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Viral Testing Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Viral Testing Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Roche Basic Information And Sales Area

Table 31: Roche. Products Portfolio

Table 32: Agilent Technologies Basic Information And Sales Area

Table 33: Agilent Technologies. Products Portfolio

Table 34: Thermo Fisher Scientific Basic Information And Sales Area

Table 35: Thermo Fisher Scientific. Products Portfolio

Table 36: QIAGEN International Basic Information And Sales Area

Table 37: QIAGEN International. Products Portfolio

Table 38: Lonza Basic Information And Sales Area

Table 39: Lonza. Products Portfolio

Table 40: Wuxi Pharmatech (Cayman) Basic Information And Sales Area

Table 41: Wuxi Pharmatech (Cayman). Products Portfolio

Table 42: Merck Basic Information And Sales Area

Table 43: Merck. Products Portfolio

Table 44: Eurofins Scientific Basic Information And Sales Area

Table 45: Eurofins Scientific. Products Portfolio

Table 46: General Electric Basic Information And Sales Area

Table 47: General Electric. Products Portfolio

Table 48: Danaher Basic Information And Sales Area

Table 49: Danaher. Products Portfolio

Table 50: Bio-Rad Laboratories Basic Information And Sales Area

Table 51: Bio-Rad Laboratories. Products Portfolio

Table 52: BD Basic Information And Sales Area

Table 53: BD. Products Portfolio

Table 54: Biospherix Basic Information And Sales Area

Table 55: Biospherix. Products Portfolio

Table 56: Novogene Corporation Basic Information And Sales Area

Table 57: Novogene Corporation. Products Portfolio

Table 58: Sartorius Basic Information And Sales Area

Table 59: Sartorius. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global Viral Testing Market Value (USD Million) By Region

Table 65: Global Viral Testing Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Viral Testing Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.72 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche; Agilent Technologies; Thermo Fisher Scientific; QIAGEN International; Lonza; Wuxi Pharmatech (Cayman); Merck; Eurofins Scientific; General Electric; Danaher; Bio-Rad Laboratories; BD; Biospherix; Novogene Corporation; Sartorius
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

The global shortage of reagents and other essential supplies is affecting the production and distribution of viral testing kits, thereby limiting the Viral Testing market size.

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Viral Testing Segmentation Breakdown12 items

Application

Laboratory

Hospital

Home Care

Academic Institute

Types

Direct Fluorescent Antibody (DFA) Test

Immunochromatographic Assay

RT-PCR-Based Test

Agglutination Assay

Flow-Through Assay

Solid-Phase Assay

Regional Insights

Loading chart…

Competitive Landscape

Roche: regional expansion

Agilent Technologies: innovation pipeline

Thermo Fisher Scientific: vertical integration

QIAGEN International: premium pricing

Lonza: local manufacturing

Wuxi Pharmatech: OEM tie-ups

Key Viral Testing Companies15 items

Roche

Agilent Technologies

Thermo Fisher Scientific

QIAGEN International

Lonza

Wuxi Pharmatech (Cayman)

Merck

Eurofins Scientific

General Electric

Danaher

Bio-Rad Laboratories

Biospherix

Novogene Corporation

Sartorius

Market Ecosystem

Raw material suppliers — providing reagents and consumables

Technology providers — developing diagnostic platforms

OEMs / manufacturers — producing testing equipment

System integrators / EPCs — configuring testing systems

Distributors / channel partners — supplying testing solutions

Service providers / after-sales — offering maintenance and support

Regulators/standards bodies — establishing testing protocols

Recent Industry Insights

Analyst Overview

Table of Contents